Working With Patients With Chronic Digestive Diseases

References

Ananthakrishnan, A. N. (2015). Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol, 12(4), 205-217. doi:10.1038/nrgastro.2015.34

Benchimol, E. I., Bernstein, C. N., Bitton, A., Murthy, S. K., Nguyen, G. C., Lee, K., . . . Kaplan, G. G. (2018). The Impact of Inflammatory Bowel Disease in Canada 2018: A Scientific Report from the Canadian Gastro-Intestinal Epidemiology Consortium to Crohn’s and Colitis Canada. Journal of the Canadian Association of Gastroenterology, 2(Supplement_1), S1-S5. doi:10.1093/jcag/gwy052

Bernstein, C. N., Rawsthorne, P., Cheang, M., & Blanchard, J. F. (2006). A population-based case control study of potential risk factors for IBD. Am J Gastroenterol, 101(5), 993-1002. doi:10.1111/j.1572-0241.2006.00381.x

Black, C.J., Thakur, E.R., Houghton, L.A., Quigley, E.M.M., Moayyedi, P. & Ford, A.C. Efficacy of psychological therapies in irritable bowel syndrome: systematic review and network meta-analysis. (2020). Gut, 69(8), 1441-1451. doi: 10.1136/gutjnl-2020-321191.

Czuber-Dochan, W., Ream, E., & Norton, C. (2013). Review article: Description and management of fatigue in inflammatory bowel disease. Aliment Pharmacol Ther, 37(5), 505-516. doi:10.1111/apt.12205

Ford, A.C., Lacy, B.E., & Talley N.J. (2017). Irritable bowel syndrome. N Engl J Med, 376, 2566-2578. doi: 10.1056/NEJMra1607547

Fourie, S., Jackson, D., & Aveyard, H. (2018). Living with Inflammatory Bowel Disease: A review of qualitative research studies. Int J Nurs Stud, 87, 149-156. doi:10.1016/j.ijnurstu.2018.07.017

Franklin, C. L., Raines, A. M., Cuccurullo, L. J., Chambliss, J. L., Maieritsch, K. P., Tompkins, A. M., & Walton, J. L. (2018). 27 ways to meet PTSD: Using the PTSD-checklist for DSM-5 to examine PTSD core criteria. Psychiatry Res, 261, 504-507. doi:10.1016/j.psychres.2018.01.021

Gracie, D. J., Guthrie, E. A., Hamlin, P. J., & Ford, A. C. (2018). Bi-directionality of Brain-Gut Interactions in Patients With Inflammatory Bowel Disease. Gastroenterology, 154(6), 1635-1646 e1633. doi:10.1053/j.gastro.2018.01.027

Grover, M., Herfarth, H., & Drossman, D. A. (2009). The functional-organic dichotomy: postinfectious irritable bowel syndrome and inflammatory bowel disease-irritable bowel syndrome. Clin Gastroenterol Hepatol, 7(1), 48-53. doi:10.1016/j.cgh.2008.08.032

Houghton, L. A., Lea, R., Agrawal, A., Reilly, B., & Whorwell, P. J. (2006). Relationship of abdominal bloating to distention in irritable bowel syndrome and effect of bowel habit. Gastroenterology, 131(4), 1003-1010. doi:10.1053/j.gastro.2006.07.015

Iqbal, S. & Quigley, E.M.M. (2016). Progress in our understanding of the gut microbiome: Implications for the clinician. Current Gastroenterology Reports, 18(49), doi.org/10.1007/s11894-016-0524-y

Kaplan, G. G. (2015). The global burden of IBD: from 2015 to 2025. Nature Reviews Gastroenterology & Hepatology, 12(12), 720-727. doi:10.1038/nrgastro.2015.150

Keefer, L., Taft, T.H., Kiebles, J.L., Martinovich, Z., Barrett, T.A., & Palsson, O.S. (2013). Aliment Pharmacol Ther, 38(7), 761-771. doi: 10.1111/apt.12449.

Keohane, J.M.B., O’Mahony, C., O’Mahony, L., O’Mahony, S., Quigley, E.M., Shanahan, F. (2010). Irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease: A real association or reflection of occult inflammation? Am J of Gastroenterol, 105(8), 1789-1794. doi: 10.1038/ajg.2010.156

Kinsey, L., & Burden, S. (2016). A survey of people with inflammatory bowel disease to investigate their views of food and nutritional issues. Eur J Clin Nutr, 70(7), 852-854. doi:10.1038/ejcn.2016.57

Kinsinger, S.W. (2017). Cognitive-behavioral therapy for patients with irritable bowel syndrome: current insights. Psychol Res Behav Manag, 10, 231-237. doi: 10.2147/PRBM.S120817

Labus, J. S., Bolus, R., Chang, L., Wiklund, I., Naesdal, J., Mayer, E. A., & Naliboff, B. D. (2004). The Visceral Sensitivity Index: development and validation of a gastrointestinal symptom-specific anxiety scale. Aliment Pharmacol Ther, 20(1), 89-97. doi:10.1111/j.1365-2036.2004.02007.x

Levenstein, S., Prantera, C., Varvo, V., Scribano, M.L., Andreoli, C., Luzi, C…Marcheggiano, A. (2000). Stress and exacerbation in ulcerative colitis: a prospective study of patients enrolled in remission. Am J Gastroenterol, 95(5), 1213-1220. doi: 10.1111/j.1572-0241.2000.02012.x.

Lewis, S.J., & Heaton, K.W. (1997). Scand J Gastroenterol, 32(9), 920-924. doi: 10.3109/0036552970901120

Li, L., Xiong, L., Zhang, S., Yu, Q., & Chen, M. (2014). Cognitive-behavioral therapy for irritable bowel syndrome: A meta-analysis. J Psychosom Res, 77(1), 1-12. doi: 10.1016/j.jpsychores.2014.03.006.

Lindfors, P., Ljotsson, B., Bjornsson, E., Abrahamsson, H., & Simren, M. (2013). Patient satisfaction after gut-directed hypnotherapy in irritable bowel syndrome. Neurogastroenterol Motil, 25(2), 169-e186. doi:10.1111/nmo.12022

Long, M. D., & Drossman, D. A. (2010). Inflammatory bowel disease, irritable bowel syndrome, or what?: A challenge to the functional-organic dichotomy. Am J Gastroenterol, 105(8), 1796-1798. doi:10.1038/ajg.2010.162

Lovell, R. M., & Ford, A. C. (2012). Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol, 10(7), 712-721.e714. doi:10.1016/j.cgh.2012.02.029

Martin, C. R., Osadchiy, V., Kalani, A., & Mayer, E. A. (2018). The Brain-Gut-Microbiome Axis. Cell Mol Gastroenterol Hepatol, 6(2), 133-148. doi:10.1016/j.jcmgh.2018.04.003

Mayer, E. A. (2011). Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci, 12(8), 453-466. doi:10.1038/nrn3071

Mayer, E.A., Tillisch, K., & Gupta, A. (2015). Gut/brain axis and the microbiota. J Clin Invest, 125(3), 926-938. doi: 10.1172/JCI76304

Mearin, F., Lacy, B.E., Chang, L., Chey, W.D., Lembo, A.J., Simren, M., & Spiller, R. (2016). Bowel disorders. Gastroenterology, 150, 1393-1407. doi: 10.1053/j.gastro.2016.02.031

Molodecky, N. A., Soon, I. S., Rabi, D. M., Ghali, W. A., Ferris, M., Chernoff, G., . . . Kaplan, G. G. (2012). Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology, 142(1), 46-54.e42; quiz e30. doi:10.1053/j.gastro.2011.10.001

Moloney, R.D., Desbonnet, L., Clarke, G., Dinan, T.G., Cryan, J.F. (2014) The microbiome: stress, health, and disease. Mamm Genome, 25(1-2), 49-74. doi: 10.1007/s00335-013-9488-5.

Navabi, S., Gorrepati, V. S., Yadav, S., Chintanaboina, J., Maher, S., Demuth, P., . . . Coates, M. D. (2018). Influences and Impact of Anxiety and Depression in the Setting of Inflammatory Bowel Disease. Inflamm Bowel Dis, 24(11), 2303-2308. doi:10.1093/ibd/izy143

Nguyen, V. Q., Jiang, D., Hoffman, S. N., Guntaka, S., Mays, J. L., Wang, A., . . . Sorrentino, D. (2017). Impact of Diagnostic Delay and Associated Factors on Clinical Outcomes in a U.S. Inflammatory Bowel Disease Cohort. Inflamm Bowel Dis, 23(10), 1825-1831. doi:10.1097/MIB.0000000000001257

Pallis, A. G., Mouzas, I. A., & Vlachonikolis, I. G. (2004). The inflammatory bowel disease questionnaire: a review of its national validation studies. Inflamm Bowel Dis, 10(3), 261-269. doi:10.1097/00054725-200405000-00014

Palsson, O.S. (2015). Hypnosis treatment of gastrointestinal disorders: A comprehensive review of the empirical evidence. Am J Clin Hypn, 58(2), 134-158. doi: 10.1080/00029157.2015.1039114.

Palsson, O. S., Whitehead, W., Törnblom, H., Sperber, A. D., & Simren, M. (2020). Prevalence of Rome IV Functional Bowel Disorders Among Adults in the United States, Canada, and the United Kingdom. Gastroenterology, 158(5), 1262-1273.e1263. doi:10.1053/j.gastro.2019.12.021

Patrick, D. L., Drossman, D. A., Frederick, I. O., DiCesare, J., & Puder, K. L. (1998). Quality of life in persons with irritable bowel syndrome: development and validation of a new measure. Dig Dis Sci, 43(2), 400-411. doi:10.1023/a:1018831127942

Peery, A. F., Crockett, S. D., Murphy, C. C., Lund, J. L., Dellon, E. S., Williams, J. L., . . . Sandler, R. S. (2019). Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018. Gastroenterology, 156(1), 254-272.e211. doi:10.1053/j.gastro.2018.08.063

Peters, S. L., Muir, J. G., & Gibson, P. R. (2015). Review article: gut-directed hypnotherapy in the management of irritable bowel syndrome and inflammatory bowel disease. Aliment Pharmacol Ther, 41(11), 1104-1115. doi:10.1111/apt.13202

Peters, S. L., Yao, C. K., Philpott, H., Yelland, G. W., Muir, J. G., & Gibson, P. R. (2016). Randomised clinical trial: the efficacy of gut-directed hypnotherapy is similar to that of the low FODMAP diet for the treatment of irritable bowel syndrome. Aliment Pharmacol Ther, 44(5), 447-459. doi:10.1111/apt.13706

Raskov, H., Burcharth, J., Pommergaard, H. C., & Rosenberg, J. (2016). Irritable bowel syndrome, the microbiota and the gut-brain axis. Gut Microbes, 7(5), 365-383. doi:10.1080/19490976.2016.1218585

Rhee, S. H., Pothoulakis, C., & Mayer, E. A. (2009). Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat Rev Gastroenterol Hepatol, 6(5), 306-314. doi:10.1038/nrgastro.2009.35

Richter, P., Werner, J., Heerlein, A., Kraus, A., & Sauer, H. (1998). On the validity of the Beck Depression Inventory. A review. Psychopathology, 31(3), 160-168. doi:10.1159/000066239

Riehl, M.E. & Keefer, L. Hypnotherapy for esophageal disorders (2015). Am J Clin Hyp, 58(1), 22-33. doi: 10.1080/00029157.2015.1025355.

Shapiro, J., El-Serag, H. B., & Chan, J. (2019). Durability and Effectiveness of Cognitive-Behavioral Therapy for Irritable Bowel Syndrome. Gastroenterology, 157(6), 1684-1686. doi:10.1053/j.gastro.2019.10.010

Sveen, J., Bondjers, K., & Willebrand, M. (2016). Psychometric properties of the PTSD Checklist for DSM-5: a pilot study. Eur J Psychotraumatol, 7, 30165. doi:10.3402/ejpt.v7.30165

Taft, T. H., Bedell, A., Craven, M. R., Guadagnoli, L., Quinton, S., & Hanauer, S. B. (2019). Initial Assessment of Post-traumatic Stress in a US Cohort of Inflammatory Bowel Disease Patients. Inflamm Bowel Dis, 25(9), 1577-1585. doi:10.1093/ibd/izz032

Taft, T. H., Triggs, J. R., Carlson, D. A., Guadagnoli, L., Tomasino, K. N., Keefer, L., & Pandolfino, J. E. (2018). Validation of the oesophageal hypervigilance and anxiety scale for chronic oesophageal disease. Aliment Pharmacol Ther, 47(9), 1270-1277. doi:10.1111/apt.14605

Torres, J., Bonovas, S., Doherty, G., Kucharzik, T., Gisbert, J. P., Raine, T., . . . Fiorino, G. (2020). ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment. J Crohns Colitis, 14(1), 4-22. doi:10.1093/ecco-jcc/jjz180

van Langenberg, D. R., & Gibson, P. R. (2010). Systematic review: fatigue in inflammatory bowel disease. Aliment Pharmacol Ther, 32(2), 131-143. doi:10.1111/j.1365-2036.2010.04347.x

Van Oudenhove, L., Crowell, M.D., Drossman, D.A., Halpert, A.D., Keefer, L., Lackner, J.M…Levy, R.L. (2016). Biopsychosocial aspects of functional gastrointestinal disorders. Gastroenterology, 150(6), 1355-1367. doi: 10.1053/j.gastro.2016.02.027.

Wiklund, I. K., Junghard, O., Grace, E., Talley, N. J., Kamm, M., Veldhuyzen van Zanten, S., . . . Schoenfeld, P. (1998). Quality of Life in Reflux and Dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg Suppl(583), 41-49. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/10027672

Windsor, J. W., & Kaplan, G. G. (2019). Evolving Epidemiology of IBD. Curr Gastroenterol Rep, 21(8), 40. doi:10.1007/s11894-019-0705-6